Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02168088 · ClinicalTrials.gov registry record
Molecular Autopsy Study
A clinical trial of Sudden Unexplained Death, sponsored by Scripps Translational Science Institute.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT02168088 is a study of Sudden Unexplained Death that is actively recruiting participants, run by Scripps Translational Science Institute. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02168088, a study of Sudden Unexplained Death, is actively recruiting participants, sponsored by Scripps Translational Science Institute.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This study seeks to incorporate genetic testing into the postmortem examination of cases of sudden unexplained death.
Conditions Studied
Study Locations (1)
California
- Scripps Translational Science Institute - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2014-06 |
| Est. Completion | 2030-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02168088
The ClinicalTrials.gov registry entry for NCT02168088 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Scripps Translational Science Institute, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sudden Unexplained Death appearing as the primary indexed condition, and to 0 interventions.
NCT02168088 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02168088 about?
NCT02168088 is a clinical study titled "Molecular Autopsy Study". This study seeks to incorporate genetic testing into the postmortem examination of cases of sudden unexplained death.
What is the current status of trial NCT02168088?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2014-06. Estimated completion is 2030-06.
What conditions does trial NCT02168088 study?
This clinical trial studies the following conditions: Sudden Unexplained Death.
Who is sponsoring clinical trial NCT02168088?
This trial is sponsored by Scripps Translational Science Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02168088 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.